These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8364199)

  • 1. Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia.
    Wierenga EA; Backx B; Snoek M; Koenderman L; Kapsenberg ML
    Blood; 1993 Sep; 82(5):1471-9. PubMed ID: 8364199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
    Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
    Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Warringa RA; Koenderman L; Kok PT; Kreukniet J; Bruijnzeel PL
    Blood; 1991 Jun; 77(12):2694-700. PubMed ID: 1646045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
    Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
    Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5.
    Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M
    Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals.
    Warringa RA; Mengelers HJ; Kuijper PH; Raaijmakers JA; Bruijnzeel PL; Koenderman L
    Blood; 1992 Apr; 79(7):1836-41. PubMed ID: 1558975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
    Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
    J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
    Sehmi R; Wardlaw AJ; Cromwell O; Kurihara K; Waltmann P; Kay AB
    Blood; 1992 Jun; 79(11):2952-9. PubMed ID: 1316789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human atopen-specific types 1 and 2 T helper cell clones.
    Wierenga EA; Snoek M; Jansen HM; Bos JD; van Lier RA; Kapsenberg ML
    J Immunol; 1991 Nov; 147(9):2942-9. PubMed ID: 1680923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of GM-CSF in differentiating eosinophils of atopic and atopic asthmatic subjects.
    Gauvreau GM; O'Byrne PM; Moqbel R; Velazquez J; Watson RM; Howie KJ; Denburg JA
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):55-62. PubMed ID: 9651180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-induced release of GM-CSF and IL-8 in vitro by nasal polyp tissue from atopic subjects prolongs eosinophil survival.
    Park HS; Jung KS; Shute J; Roberts K; Holgate ST; Djukanović R
    Eur Respir J; 1997 Jul; 10(7):1476-82. PubMed ID: 9230233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of eosinophil chemotaxis by interleukin-5.
    Warringa RA; Schweizer RC; Maikoe T; Kuijper PH; Bruijnzeel PL; Koendermann L
    Am J Respir Cell Mol Biol; 1992 Dec; 7(6):631-6. PubMed ID: 1449809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis.
    Desreumaux P; Bloget F; Seguy D; Capron M; Cortot A; Colombel JF; Janin A
    Gastroenterology; 1996 Mar; 110(3):768-74. PubMed ID: 8608886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human airway and peripheral blood eosinophils enhance Th1 and Th2 cytokine secretion.
    Liu LY; Mathur SK; Sedgwick JB; Jarjour NN; Busse WW; Kelly EA
    Allergy; 2006 May; 61(5):589-97. PubMed ID: 16629789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils.
    Lopez AF; Vadas MA; Woodcock JM; Milton SE; Lewis A; Elliott MJ; Gillis D; Ireland R; Olwell E; Park LS
    J Biol Chem; 1991 Dec; 266(36):24741-7. PubMed ID: 1761568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
    Lantero S; Sacco O; Scala C; Rossi GA
    J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 induces chemotaxis of blood eosinophils from atopic dermatitis patients, but not from normal individuals.
    Dubois GR; Bruijnzeel-Koomen CA; Bruijnzeel PL
    J Invest Dermatol; 1994 Jun; 102(6):843-6. PubMed ID: 8006446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
    Sonoda Y; Arai N; Ogawa M
    Leukemia; 1989 Jan; 3(1):14-8. PubMed ID: 2642572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
    Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
    Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 treatment-associated eosinophilia is mediated by interleukin-5 production.
    Macdonald D; Gordon AA; Kajitani H; Enokihara H; Barrett AJ
    Br J Haematol; 1990 Oct; 76(2):168-73. PubMed ID: 2094320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.